In short
Menopause treatment in Dubai at this clinic covers perimenopause, menopause and female hormone problems, with HRT as a patch, gel or tablet, vaginal oestrogen and non-hormonal medicines.
- Transdermal 17-beta oestradiol is the usual first choice, because it carries a lower clot and stroke risk than tablets.
- Micronised progesterone is preferred over older synthetic progestins.
- Compounded hormones and saliva testing are not used.
For a healthy woman under 60 or within 10 years of her last period, the benefits of treatment outweigh the risks. That is the group this clinic is built for.
Who This Service Is For
Who is this clinic for?
Women whose symptoms have started to interfere with sleep, work or relationships, and who want a plan rather than reassurance.
- Perimenopause. Cycles changing, flushes starting, mood shifting, and still needing contraception
- Menopause. Twelve months past the last period, with symptoms that have not settled
- Already on treatment. A prescription that has been repeated for years without anyone re examining the dose
- Hormone problems before menopause. Irregular cycles, high prolactin, PCOS, or periods stopping before 40
- On compounded hormones. Wanting to move to a regulated equivalent at a known dose
Who is it not for?
Hormone therapy is not used where there is a history of breast cancer, coronary heart disease, stroke, a previous clot, active liver disease, or unexplained vaginal bleeding that has not been investigated.
Where that applies, non hormonal treatment is still available and still works. What is not on offer is a way around a contraindication.
Why does this clinic exist?
Because menopause care fell off a cliff after 2002 and has never recovered. Hormone therapy use fell from 27 per cent of women in 1999 to 4.7 per cent by 2020.
Training followed. In one survey of final year internal medicine and obstetrics residents, 30 to 50 per cent said they felt not at all prepared to manage menopausal women, and half could not identify the right treatment for a 52 year old with severe symptoms.
Treatment Programs Under This Pillar
HRT Consultation
Start here if you want to know whether hormone therapy is right for you. The diagnosis, your personal risk, and the absolute numbers in writing before you decide.
View TreatmentHormone Replacement Therapy
The overview: every HRT form, why the route matters, why progesterone is needed, and the risks in cases per 1,000 rather than percentages.
View TreatmentHRT Patches and Oestrogen Gel in Dubai
Estradiol through the skin, the first choice for most women: patch or gel, doses, progesterone plan and follow-up.
View TreatmentHRT Tablets in Dubai
Oral estradiol for healthy women under 60: who tablets suit, regimens by stage, bleeding and effects on thyroid tablets.
View TreatmentVaginal Oestrogen in Dubai
Low-dose vaginal oestrogen for dryness, pain during sex and recurrent urinary infections after menopause.
View TreatmentNon-Hormonal Menopause Treatment in Dubai
Hot flush relief without hormones: fezolinetant, SSRIs, SNRIs and gabapentin, and why supplements do not work.
View TreatmentBioidentical Hormone Therapy
What bioidentical actually means, why compounded mixtures, pellets and saliva testing are advised against, and what is prescribed instead.
View TreatmentWomen’s Hormone Optimization
For women under 45 with irregular or absent periods. Which tests help, when in the cycle to take them, and the diagnoses behind a hormone question.
View TreatmentWhy Physician-Led Care Matters
What actually changes at menopause?
Oestrogen production falls, and the symptoms that respond to replacing it are specific: hot flushes, night sweats, the broken sleep they cause, vaginal dryness, and in many women mood during the transition.
That list is shorter than the one menopause is often blamed for. Weight change, fatigue and poor concentration in midlife are common and have many causes, and they do not reliably improve on oestrogen. Separating the two is most of what a good assessment does.
Timing matters more than most women are told. The transition begins on average around age 47, four years before the last period, and symptoms last a median of 7.4 years in total according to the Study of Women’s Health Across the Nation. Bone loss and cholesterol changes start before the final period, not after it.
How does care work here?
In one appointment for most women, because over the age of 45 the diagnosis does not wait on a laboratory.
| Step | What happens |
|---|---|
| 1. Assessment | Symptoms, cycle pattern and what they cost you. Over 45 this is what makes the diagnosis. A hormone blood test adds nothing and can mislead |
| 2. Your personal risk | Breast cancer history, clots, stroke, heart and liver disease, migraine, blood pressure, weight, and whether you still have a womb. This decides the route as much as the answer |
| 3. The numbers | The absolute figures for your age group, as cases per 1,000 women over five years, so the decision is yours on real information |
| 4. Treatment and review | A written plan, a first review at three months, then yearly. Stopping is planned rather than abrupt |
Over the age of 45 the diagnosis is made from your cycle pattern and your symptoms. A hormone blood test adds nothing and can mislead. Why blood tests are not used.
What separates proper menopause care from a hormone shop?
Four things, and they are worth checking before you book anywhere:
- The diagnosis is made from your symptoms and cycle, not from a hormone panel. Over 45 a panel adds nothing, and during the transition levels swing from week to week.
- You are given absolute numbers, not reassurance. Three extra breast cancer cases per 1,000 women over five years and a 24 percent relative increase describe the same finding, and only one of them is usable.
- Endometrial protection is not optional. Any woman with a womb taking systemic oestrogen needs a progestogen, at an adequate dose, monthly.
- The dose is set by your symptoms, not by a test. Dosing steered by hormone levels, and by saliva in particular, belongs to compounded programmes and has no evidence behind it.
Compounded hormone mixtures and saliva testing are not used here, and the reason is not brand preference. What is wrong with compounded hormones.
What happens to your bones?
Bone loss begins during the transition, before the final period, and accelerates around it.
Hormone therapy increases bone density and reduces fractures while it is taken, and bone loss resumes when it stops. It is not prescribed to prevent osteoporosis in a woman without symptoms, but for a woman taking it for flushes the bone effect is a genuine additional benefit.
Where hormone therapy is not suitable and fracture risk is high, osteoporosis is treated in its own right with medication intended for that purpose.
Where should you start?
The right starting page depends on your question: your symptoms, the decision about HRT, a specific treatment or your personal situation. Each page covers one subject in depth.
- A first check: the 2-minute menopause self-check, based on the Menopause Rating Scale.
- Symptoms: menopause, perimenopause, hot flushes, hormonal sleep disturbance, hormonal mood changes, brain fog in menopause and low libido in women.
- The decision: HRT consultation, whether hormone therapy fits you and the risks in absolute numbers.
- The treatment: hormone replacement therapy as the overview, HRT patches and oestrogen gel, HRT tablets, vaginal oestrogen, non-hormonal menopause treatment and bioidentical hormone therapy.
- Your situation: perimenopause treatment, early menopause treatment, HRT after hysterectomy, HRT with a family history of breast cancer, HRT for women over 60 and hormone assessment for women under 45.
- Ongoing care: the Women’s Hormone Membership, including the yearly review of dose, bleeding and screening.
- Single questions: what HRT costs in Dubai and bleeding on HRT.
Menopause care in Dubai and the UAE
What women here are dealing with
Two local findings are worth knowing, because both change what belongs in the plan.
Mood during the transition is common. A study of 279 peri- and postmenopausal women in the UAE, with data collected in 2024, found 56.6 percent had at least mild depression and 10 percent had severe depression, with perimenopausal women affected more than postmenopausal ones. Poor sleep, inactivity and smoking were among the associated factors. It is one cross-sectional study, so it shows association rather than cause, but it is reason enough to ask about mood routinely.
Bone deserves extra attention. A 2025 systematic review of 35 studies and 28,260 people in the UAE found a mean vitamin D level in adults of 17.63 ng/mL, below the 20 ng/mL threshold usually used to define deficiency. Bone loss accelerates around the menopause, so vitamin D, calcium and weight-bearing exercise belong alongside whatever is done for symptoms.
Access, prescriptions and moving countries
Hormone preparations are prescription medicines in the UAE, in the regulated categories of the classification maintained by Dubai Health Authority Drug Control.
Which brands and pack sizes are stocked varies over time and between pharmacies, so the exact product is settled at the prescription stage. Registration in the UAE, availability, and insurance cover are three separate questions and are best not assumed to move together.
For women who move between countries mid-treatment, the most useful thing to bring is the record: preparation, dose, route, start date, progestogen, bleeding pattern, and the last mammogram result. Treatment brought in from abroad may need a ministry permit. What the permit needs.
Why bone health needs extra attention here
Because vitamin D levels in the UAE are low across the population, and the transition is exactly when bone loss speeds up.
A 2025 systematic review pooling 35 studies and 28,260 people in the UAE found a mean vitamin D level in adults of 17.63 ng/mL, which sits below the 20 ng/mL threshold commonly used to define deficiency. The reasons are not mysterious: months of the year when outdoor activity is impractical, indoor working days, and clothing and sun avoidance patterns.
The practical consequence for a woman going through the menopause here is that vitamin D and calcium intake, and weight-bearing and resistance exercise, belong in the plan alongside whatever is done for symptoms. Vitamin D status is part of the baseline blood tests.
Care for your situation
The same medical approach, planned around where you are in life.
Perimenopause Treatment
Symptoms treated while periods continue, with a regimen that fits your cycle.
Read more →Breast cancer in the familyHRT with Family History of Breast Cancer
Your risk in real numbers, the HRT types with less breast risk and the alternatives.
Read more →Over 60HRT for Women Over 60
Whether to start, continue or stop, and why patches and gels change the risk.
Read more →Under 45Early Menopause Treatment
Hormone therapy that protects bones and heart, with honest answers on fertility.
Read more →After hysterectomyHRT After Hysterectomy
Oestrogen alone, the right dose after removed ovaries and your risks weighed first.
Read more →
How the Consultation Works
-
1
The history
How your cycles changed, which symptoms bother you most, and what you have already tried. In perimenopause this is worth more than any hormone level, because levels swing week to week and can look normal on a good month.
-
2
The risk calculation
Cardiovascular and breast cancer risk are worked out before anything is prescribed, along with screening status and any contraindication. These decide the route and sometimes the answer.
-
3
Targeted testing only where it helps
Hormone therapy is dosed by symptoms. Where cycles have stopped or become irregular before menopause, a short panel is used instead: pregnancy test, prolactin, TSH, FSH and oestradiol, with androgens where PCOS is in the picture.
-
4
The plan and the first review
A named dose, a named preparation, a clear answer on endometrial protection, and a review at three to four weeks, which is when hot flush relief should be showing.
Frequently Asked Questions
For a healthy woman with moderate to severe symptoms who is within ten years of her last period, or under 60, the balance is favourable. In women starting between 50 and 59, the Women's Health Initiative figures work out at a few extra cases per 1,000 over five years, and deaths from any cause were lower rather than higher in both treatment groups.
Not to make the diagnosis. Over 45, the transition is diagnosed from your cycle pattern and symptoms. FSH is often measured and offers no additional information, because levels swing from week to week. Other blood tests are selected according to symptoms, history and risk. Vitamin D is not a routine test for every otherwise healthy woman.
A patch or gel is usually the first choice, because oestrogen through the skin avoids the first pass through the liver. Oral oestrogen raises the risk of clots and stroke. Both relieve hot flushes equally well, so the choice is about safety rather than effectiveness.
No. The standard figure has been five years and not beyond 60, but both the Menopause Society and the American College of Obstetricians and Gynecologists say the decision should be individualised and not based on age alone. Symptoms last a median of 7.4 years, and over 40 percent of women aged 60 to 65 still have them.
Regulated body-identical hormones, yes: 17-beta oestradiol and micronised progesterone are exactly that, and are what is prescribed here. Custom-compounded mixtures, implanted pellets and saliva-guided dosing are not offered, because there are no randomised trials of their efficacy or safety and no oversight of their contents or dose.
It often helps mood during the transition, when mood symptoms are more common than before or after it. It is not a treatment for depression. In a 2026 UAE study of 279 peri- and postmenopausal women, 56.6 percent had at least mild depression, so mood is asked about routinely here.
Yes, and it is settled at the same appointment. Hormone therapy is not contraception. NHS patient guidance is contraception for two years after the last period if you are between 40 and 49, and one year if you are 50 or over.
There are tested alternatives: citalopram or escitalopram, venlafaxine, gabapentin, oxybutynin, and the neurokinin blockers fezolinetant and elinzanetant, plus cognitive behavioural therapy. Vaginal symptoms are treated locally. Supplements, soy, black cohosh and acupuncture are not among the options the Menopause Society recommends.
Yes. Bring the preparation and dose, the route, when it started, the progestogen if any, the bleeding pattern and your last mammogram result. With that, the review can continue treatment rather than restart the assessment.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- The 2022 hormone therapy position statement of The North American Menopause Society
- The 2023 nonhormone therapy position statement of The North American Menopause Society
- Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women (Women's Health Initiative)
- Effects of conjugated equine estrogen in postmenopausal women with hysterectomy (Women's Health Initiative)
- Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials
- Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials
- Duration of menopausal vasomotor symptoms over the menopause transition (SWAN)
- Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement
- Depression across the menopausal stages in the United Arab Emirates: prevalence and risk factors
- Vitamin D status among apparently healthy individuals in the UAE: a systematic review
- Drug Control
- Understanding menopause: patient information leaflet
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.